Feedback

Browsing by L

Use an asterisk (*) for partial word searches (e.g. pemph*)

120 results found.

1.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

2.
Ordering Recommendation:  

Refer to aruplab.com/bodyfluids for clinical indications and interpretive information.

3.
Ordering Recommendation:  

Do not use to detect myocardial injury. Cardiac troponins [troponin I (0090613)or troponin T (0098803)] are the recommended tests for diagnosis and management of acute coronary syndrome. In rare cases, this test may be used to evaluate elevated lactate dehydrogenase associated with non-cardiac muscle injury.

4.
5.
Ordering Recommendation:  

When considering pyruvic acid testing, this is the preferred test.  This test reports concentrations for lactate, pyruvate, and the L:P ratio on the same specimen.

6.
7.
8.
9.
Ordering Recommendation:  

Do not use to diagnose inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS); may be used for monitoring IBD activity.

10.
11.
Ordering Recommendation:  

Quantify and determine clonality of free lambda light chains (Bence Jones protein) in urine. Monitor treatment response if gammopathy is known to be lambda.

12.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

13.
Ordering Recommendation:  

Preferred fetal lung maturity test.

14.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

15.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

16.
17.
Ordering Recommendation:  

Differentiates LDL particles with respect to size to identify individuals with phenotype A (large LDL particles) or B (small LDL particles); considered as a non-traditional CVD risk marker.

18.
19.
Ordering Recommendation:  

May be useful in determining past exposure to lead. Not recommended for the routine assessment of lead toxicity.

20.
Ordering Recommendation:  

Recommended for routine testing for lead exposure in pediatric populations. Confirm elevated results with a venous sample (0020098).

21.
Ordering Recommendation:  

Recommended for routine testing for lead exposure. For occupational exposure, consider Lead, Industrial Exposure Panel, Adults (0025016).

22.
Ordering Recommendation:  

Recommended for the assessment of industrial lead exposure in adults and provides exposure guidance in accordance with OSHA regulations. To assess lead exposure in a non-occupational setting, Lead, Blood (Venous) testing (0020098) is preferred.

23.
24.
Ordering Recommendation:  

Not recommended for the routine assessment of lead toxicity.

25.
Ordering Recommendation:  

May be useful in the assessment of chronic lead exposure or in monitoring chelation therapy. For routine testing of lead exposure, Lead, Blood (Venous) (0020098) is preferred. For occupational exposure, consider Lead, Industrial Exposure Panel, Adults (0025016).

26.
27.
Ordering Recommendation:  

Preferred fetal lung maturity test is Lamellar Body Counts (0080940). Lecithin-sphigomyelin ratio may be useful adjucating immature LBC or PG. Results require >24 hrs unless performed at a local laboratory.

28.
Ordering Recommendation:  

Therapeutic monitoring and evaluating full elimination of the drug (eg, toxicity, pregnancy).

29.
Ordering Recommendation:  

Provide retrospective evidence of suspected Legionella pneumophila infection.

30.
Ordering Recommendation:  

May be useful when acute legionellosis is suspected; however, urine antigen testing is preferred (0070322).

31.
Ordering Recommendation:  

Provide retrospective evidence of suspected Legionella pneumophila infection.

32.
Ordering Recommendation:  

May be useful when acute legionellosis is suspected; however, urine antigen testing is preferred (0070322).

33.
Ordering Recommendation:  

Provide retrospective evidence of suspected Legionella pneumophila infection.

34.
Ordering Recommendation:  

Use for the rapid identification of L. pneumophila; sensitivity is dependent on patient population and specimen type. Molecular testing is generally preferred; refer to Legionella spp. by PCR (2010125).

35.
Ordering Recommendation:  

Detect Legionella species.

36.
Ordering Recommendation:  

Gold standard test; detects L. pneumophila and other Legionella species in clinical specimens.

37.
Ordering Recommendation:  

This is a second tier test and REQUIRES PERMISSION from  ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.

38.
Ordering Recommendation:  

Diagnostic testing for Legius syndrome. Predictive testing for Legius syndrome.

39.
Ordering Recommendation:  

Preferred test for confirming diagnosis of LS in symptomatic individuals who test negative for NF1 gene mutations.

40.
Ordering Recommendation:  

Aid in the diagnosis of leishmaniasis.

41.
42.
Ordering Recommendation:  

Aids in the detection of acute leptospirosis.

43.
Ordering Recommendation:  

May provide definitive diagnosis, but sensitivity is low and may not become positve for weeks.

44.
Ordering Recommendation:  

Screen for obstructive biliary disease.

45.
Ordering Recommendation:  

Aids in diagnosis of
• Leucine-rich Glioma Inactivated 1 Protein (LGI1) Antibody disorders associated with limbic encephalitis, hyponatremia, myoclonic movements. Disorders are rarely associated with tumors.
• Contactin Associated Protein 2 (CASPR2) Antibody disorders associated with acquired neuromyotonia, limbic encephalitis, painful neuropathy, and Morvan syndrome.
Use to manage antibody-positive (LGI1 or CASPR2) individual following immunotherapy and/or plasmapheresis.

46.
Ordering Recommendation:  

Aids in diagnosis of Leucine-rich Glioma Inactivated 1 Protein (LGI1) antibody disorders associated with limbic encephalitis, hyponatremia, myoclonic movements. Disorders are rarely associated with tumors. Use to manage antibody-positive (LGI1) individual following immunotherapy and/or plasmapheresis.

47.
Ordering Recommendation:  

Aid in evaluation of hematopoietic neoplasms (ie, leukemia, lymphoma). Monitor therapy in patients with established diagnosis of hematopoietic neoplasms.

48.
Ordering Recommendation:  

Aids in the diagnosis of type I and II leukocyte adhesion deficiency. Panel measures CD11b, CD15, and CD18 on neutrophils.

49.
Ordering Recommendation:  

Aid in differential diagnosis of neutrophilia, including chronic myeloid leukemia (CML) and leukemoid reaction.

50.
51.
52.
Ordering Recommendation:  

Appropriate initial test for Li-Fraumeni  syndrome (LFS).

53.
Ordering Recommendation:  

Most comprehensive test for Li-Fraumeni  syndrome (LFS).

54.
Ordering Recommendation:  

This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the combined sequencing and deletion/duplication test.

55.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

56.
57.
58.
Ordering Recommendation:  

Refer to aruplab.com/bodyfluids for clinical indications and interpretive information.

59.
60.
Ordering Recommendation:  

Non-specific tumor marker; may be useful for monitoring patients with various malignant conditions.

61.
Ordering Recommendation:  

Use to assess cardiovascular disease risk and guide therapy.

62.
Ordering Recommendation:  

Use to assess cardiovascular disease risk and guide therapy.

63.
Ordering Recommendation:  

Standard fasting lipid panel (0020421) is preferred for most individuals. Not recommended for cardiovascular disease risk assessment in most individuals.

64.
65.
Ordering Recommendation:  

Not recommended for cardiovascular risk assessment in asymptomatic adults. May aid in CVD risk stratification in specific populations.

66.
Ordering Recommendation:  

Determine the Fredrickson classification of individuals with hyperlipoproteinemia. Most useful for identifying the Type III phenotype.

67.
Ordering Recommendation:  

Determine the Fredrickson classification of individuals with hyperlipoproteinemia. Most useful for identifying the Type III phenotype.

68.
69.
70.
71.
72.
73.
74.
Ordering Recommendation:  

Use to evaluate for autoimmune hepatitis of unknown etiology.

75.
Ordering Recommendation:  

Noninvasive, serum surrogate marker test for assessment of liver fibrosis in patients with chronic viral hepatitis.

76.
Ordering Recommendation:  

Only intended for use in patients with non-alcoholic liver disease (NAFLD); results may be inaccurate in patients with other etiologies of liver disease.

77.
78.
79.
Ordering Recommendation:  

Confirm suspected laminopathy caused by LMNA deletions/duplications including Emery-Dreifuss muscular dystrophy type 2, Limb-girdle muscular dystrophy 1B or dilated cardiomyopathy.

80.
Ordering Recommendation:  

Confirm suspected laminopathy caused by LMNA mutations including Hutchinson-Gilford progreria, Emery-Dreifuss muscular dystrophy type 2, Limb-girdle muscular dystrophy 1B, Charcot-Marie-Tooth 2B1, Dunnigan type familial partial lipodystrophy, mandibulo-acral dysplasia, atypical Werner syndrome, restrictive dermopathy or dilated cardiomyopathy.

81.
Ordering Recommendation:  

Confirm clinical diagnosis of Loeys-Dietz Syndrome.

82.
Ordering Recommendation:  

Refer to Additional Technical Information document.

83.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

84.
85.
86.
Ordering Recommendation:  

Screening panel detects EGFR mutations (pyrosequencing), ALK and ROS1 fusion proteins (IHC).

87.
Ordering Recommendation:  

Screening panel detects EGFR and KRAS mutations (pyrosequencing), ALK and ROS1 fusion proteins (IHC).

88.
Ordering Recommendation:  

Use for unexplained prolonged PTT or for patients with a significant probability of having antiphospholipid syndrome (APS).  For APS, order with anticardiolipin (aCL) (0099344) and anti-beta-2-glycoprotein 1 (anti-β2GP1) (0050321) antibody IgG and IgM assays.

89.
Ordering Recommendation:  

Recommended for the evaluation of systemic lupus erythematosus (SLE).

90.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

91.
92.
Ordering Recommendation:  

Test is intended for patients 2 weeks-6 years of age. For patients 7 years and older, order Luteinizing Hormone, Serum (0070093).

93.
94.
95.
Ordering Recommendation:  

Evaluate patients with suspected immunodeficiency diseases, including severe combined immunodeficiency.

96.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

97.
98.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

99.
Ordering Recommendation:  

Aids in clinical management of HIV-positive individuals.

100.
Ordering Recommendation:  

Absolute CD4 count is sufficient for routine HIV monitoring.

101.
Ordering Recommendation:  

Absolute CD4 count is sufficient for routine HIV monitoring.

102.
Ordering Recommendation:  

Absolute CD4 count is sufficient for routine HIV monitoring.

103.
Ordering Recommendation:  

Support the diagnosis of sarcoidosis.

104.
Ordering Recommendation:  

Evaluate for primary immunodeficiencies, including severe combined immunodeficiency, and monitor immune reconstitution following transplantation.

105.
Ordering Recommendation:  

Useful for assessing primary T-cell immunodeficiency disorders.

106.
Ordering Recommendation:  

Acceptable lymphocyte subset panel for the investigation of primary immunodeficiency disorders.

107.
Ordering Recommendation:  

Monitor response to CD3 immunosuppressive therapy.

108.
Ordering Recommendation:  

Intended for TRANSPLANT patients only.

109.
Ordering Recommendation:  

Aid in the diagnosis of lymphocytic choriomeningitis (LCM) viral infection.

110.
Ordering Recommendation:  

Aid in the diagnosis of lymphocytic choriomeningitis (LCM) viral infection in CNS.

111.
Ordering Recommendation:  

Not recommended as a stand-alone test. Panel that combine slymphocytic choriomeningitis (LCM) virus IgG and IgM antibodies is preferred (2001635).

112.
Ordering Recommendation:  

Not recommended as a stand-alone test. Panel that includes lymphocytic choriomeningitis (LCM) virus IgG and IgM antibodies is preferred; refer to 2001628.

113.
Ordering Recommendation:  

Not recommended as a stand-alone test for identifying lymphocytic choriomeningitis (LCM) virus as pathology for meningitis. Panel that includes IgG and IgM antibodies is preferred (2001635).

114.
Ordering Recommendation:  

Not recommended as a stand-alone test. Panel that includes lymphocytic choriomeningitis (LCM) virus IgG and IgM antibodies is preferred (2001628).

115.
Ordering Recommendation:  

Aid in the diagnosis of aggressive large B-cell lymphoma with intermediate features between Burkitt lymphoma and diffuse large B-cell lymphoma (DLBCL) and confirmation of suspected double-hit lymphoma. Reflex testing is available; refer to (2012710).

116.
117.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

118.
119.
120.